未知生产厂商
DG031, deCODE genetics's lead compound, is being developed for the prevention of myocardial infarction, or heart attack.
DG031, deCODE genetics's lead compound, is being developed for the prevention of myocardial infarction, or heart attack.
DG031 inhibits the activity of the FLAP, or 5-lipoxygenase activating protein, that modulates the activity of the leukotriene pathway.
Investigated for use/treatment in heart disease and myocardial infarction.
